The “Microbial Metabolites and Chronic Pain” research axis explores the interactions between metabolites derived from the intestinal microbiota and the nervous system in the context of chronic pain. We are studying the role of the intestinal microbiota and its metabolites in the mechanisms of pain chronicization, in particular the involvement of the AhR/IL-22 pathway. We are also interested in the impact of microbial and/or tissue metabolites on the disturbances in “well-being” associated with chronic pain. Finally, we characterize new probiotics with anti-hyperalgesic potential, by evaluating their neuromodulatory power.
Journal articles
2025


2024


2023










2022


















2021






2020
















2019






2018








2017








2016











2015
















2014




2013


2012







2011










2010




2009




2008







2007


2006


2005


2004
2002
2001
Conference papers
2024
2023
2019
2003
2002
2001
Book sections
2018


Habilitation à diriger des recherches
2023


Poster communications
2023


2022


2021
2019
2018


2017




Theses
2018


2011

